Lipocine is trading 5.83% up now at $2.18, with no clear company-specific catalyst identified for August 14, 2026.
- The latest identified corporate announcement was August 4, 2026 financial results and a corporate update.
- August 6 coverage concerned a board appointment; neither directly explains today’s move.
- Broader market indexes are slightly lower, while volume information was unavailable.